Expression of concern

Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma

Expression of concern Details

Nature of Retraction:

Expression of concern

Citations (4)

4
Total Citations
3
Post-Retraction
(75.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
1 After 2+ years
1231 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
LncRNA ABHD11-AS1 Elevates CALM2 to Promote Metastasis of Thyroid Cancer Through Sponging miR-876-5p
Juan Lv, Fukun Chen, Ling Lv et al. (10 authors)
Biochemical Genetics
Published: Mar 2025
1231 days after retraction
METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study
Gang Huang, Yuda Qiu, Yafei Fan et al. (4 authors)
Neurochemical Research
Published: Aug 2023
12 citations
655 days after retraction
ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies
Upendarrao Golla, Kishore Sesham, Siva Dallavalasa et al. (9 authors)
Non-Coding RNA Open Access
Published: Mar 2022
18 citations
115 days after retraction
Quick Stats
Total Citations: 6
Years Since Retraction: 4.0 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers